In the SARS-CoV-2 viral infection, the disease course was more severe with longer recovery if patients had low T cell lymphocyte levels, especially in the CD8 and CD4 subpopulations [59,60]. This evidence concerns the gene CD4 and severe acute respiratory syndrome.